Showing 1 - 6 of 6
hypertension could reduce health care spending $890 billion for these cohorts while adding 75 million disability-adjusted life …
Persistent link: https://www.econbiz.de/10014591905
Basing drug reimbursement on cost-effectiveness provides too little incentives for R&D. The reason for this is that cost-effectiveness is concerned with immediate value for money. But since the price of a drug usually declines over time, the drug might well provide value for money as seen over...
Persistent link: https://www.econbiz.de/10014591975
hypertension could reduce health care spending $890 billion for these cohorts while adding 75 million disability-adjusted life …
Persistent link: https://www.econbiz.de/10005579677
Basing drug reimbursement on cost-effectiveness provides too little incentives for R&D. The reason for this is that cost-effectiveness is concerned with immediate value for money. But since the price of a drug usually declines over time, the drug might well provide value for money as seen over...
Persistent link: https://www.econbiz.de/10005246202
We analyze the value to the labor force of improvements in survival and health over the years 1970 to 1999. We find … that survival gains and reductions in the number of work-days missed due to poor health have added about 8 percent to the … are around 2%. Overall, health improvements have added $1.5 trillion to the value of labor market human capital over this …
Persistent link: https://www.econbiz.de/10014591904
We analyze the value to the labor force of improvements in survival and health over the years 1970 to 1999. We find … that survival gains and reductions in the number of work-days missed due to poor health have added about 8 percent to the … are around 2%. Overall, health improvements have added $1.5 trillion to the value of labor market human capital over this …
Persistent link: https://www.econbiz.de/10005579685